COVID-19: Rheumatology patient outcomes vary with meds
Overall, it seems DMARDs are not raising risk of severe infection, researchers say
Results from a global registry for rheumatology patients with COVID-19 suggest hospital admission for the infection is less likely for those on tumour necrosis factor (TNF) inhibitors.
But patients on high doses of prednisone (more than 10mg a day) are at greater risk of hospitalisation, the international authors report.
